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 Abstract  
Background:  Air pollution is linked to increased emergency room visits for headache and 
migraine patients frequently cite chemicals or odors as headache triggers, but the association 
between air pollutants and headache is not well-understood.  We previously reported that nasal 
administration of environmental irritants acutely increases meningeal blood flow via a TRPA1-
dependent mechanism, involving the trigeminovascular system.  Here, we examine whether 
chronic environmental irritant exposure sensitizes the trigeminovascular system.   
Methods:  Male rats were exposed to acrolein, a TRPA1 agonist, or room air by inhalation for 4 
days prior to meningeal blood flow measurements.  Some animals were injected daily with a 
TRPA1 antagonist, AP-18 or vehicle prior to inhalation exposure.  Trigeminal ganglia were 
isolated following blood flow measurements for immunocytochemistry and/or qPCR 
determination of TRPV1, TRPA1 and CGRP levels.  
Results:  Acrolein inhalation exposure potentiated blood flow responses to both TRPA1 and 
TRPV1 agonists compared to room air.  Acrolein exposure did not alter TRPV1 or TRPA1 
mRNA levels or TRPV1 or CGRP immunoreactive cell counts in the trigeminal ganglion.  
Acrolein sensitization of trigeminovascular responses to a TRPA1 agonist was attenuated by pre-
treatment with AP-18.   
Interpretation:  These results suggest trigeminovascular sensitization as a mechanism for 
enhanced headache susceptibility after chemical exposure.     
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INTRODUCTION 
Headache is one of the most common neurological disorders, yet remains poorly 
understood and undertreated.  Migraineurs worldwide report similar headache triggers including 
air pollutants and odors (1).  Specifically, increased air pollution is correlated with an increase in 
emergency room visits for headache symptoms (2-4) and poor air quality and odors are 
commonly reported triggers of migraine (1).  Multiple Chemical Sensitivity (MCS (5)) is an 
acquired disorder associated with chemical exposure.  MCS patients report headache and other 
symptoms, although the link between chemical exposure and the induction of headache remains 
unknown.  
Activation of the trigeminovascular system is thought to play a critical role in headache.  
Release of the inflammatory peptides substance P and calcitonin gene-related peptide (CGRP) 
from trigeminal sensory neuron endings (6) produces neurogenic inflammation and 
vasodilatation in the dura (7;8), which are believed to be mechanistically linked to headache 
pain.  We have previously demonstrated that nasal administration of environmental irritants 
stimulates meningeal vasodilatation acutely via a TRPA1 receptor-dependent mechanism (9).  
This suggests a molecular mechanism for acute environmental irritant-induced headache, but 
what remains unclear is whether previous airborne chemical exposure may sensitize the 
trigeminovascular system and predispose subjects to headache.  
TRPA1 receptors have been shown to act as sensors of many environmental irritants 
including acrolein (10), formaldehyde (11), and umbellulone (12), and of pungent plant 
ingredients such as mustard oil (10;13), cinnamaldehyde (13), and allicin (10;14).  TRPA1 is an 
excitatory nonselective cation channel co-localized with CGRP in a subset of sensory neurons 
(14;15), including those of the trigeminal ganglion (TG) (16).  TRPA1 receptors are expressed in 
trigeminal sensory neurons innervating the nasal mucosa (17) where they may be activated by 
inhalants.  TRPA1 receptors are usually co-localized with TRPV1 receptors (15;18;19) and the 
two receptors have been shown to interact functionally (20).  We have demonstrated that TRPV1 
expressing neurons are important for TRPA1 responses in the nasal-meningeal pathway (21).  
Herein we examine the functional role of both receptors in meningeal vasodilatation following 
irritant exposure. 
It has been proposed that sensitization of the headache pain pathway may occur through 
repeated or sustained activation of peripheral nociceptors (22;23) but this process is not well-
understood.  Here we address the question of whether prolonged and repeated in vivo inhalation 
exposure to non-toxic levels of the TRPA1 agonist acrolein changes trigeminovascular 
responsiveness.  Furthermore, we explore whether changes in responsiveness are linked to 
changes in TRPA1, TRPV1 and/or CGRP expression.  
Methods 
All animal procedures were approved by the Institutional Animal Care and Use 
Committee at the Indiana University School of Medicine and followed the ethical guidelines of 
International Association for the Study of Pain (24).  Experiments were performed on 131 adult 
male (170-250 g) Sprague-Dawley rats (Harlan Bioproducts, IN).  Rats were housed in pairs with 
a standard light and dark cycle with free access to food and water. 
Inhalation Exposure.  Rats were exposed to acrolein by mixing acrolein gas (Air 
Liquide, Plumsteadville, PA) and room air to obtain the desired concentration.  The acrolein 
dosage (0.3 ppm) was chosen because it produced minimal or no detectable harmful effects in 
previous studies (25-27) and in our preliminary studies.  In addition, it is equivalent to the limit 
for short-term exposure recommended by National Institute of Occupational Safety and Health.  
Separate inhalation chambers (Braintree Scientific, Inc; 5.5 L total volume) and tubing were used 
for acrolein and control groups to avoid cross-contamination.  The flow rate was maintained at 
1.5 L/min and temperature and humidity were monitored in the chamber.  Rats were exposed to 
acrolein (0.32 ± 0.06 ppm (n = 52) 4 hours per day for 4 days while control animals were 
exposed to room air with the same paradigm.  Cumulative acrolein exposure for each animal was 
determined with monitoring badges placed in the chamber (Advanced Chemical Sensors Inc, 
Boca Raton, FL).  On day 5 approximately 22 hours after the last inhalation exposure, laser 
Doppler flowmetry was conducted followed by tissue collection.  Selected groups of rats 
received daily injections of vehicle (9% DMSO in sterile saline; 200 µl injection volume i.p.; n 
=45) or AP-18 (200 µg/kg; Sigma; n = 28) diluted in vehicle 30 min before inhalation chamber 
exposure.  Animals exposed to room air gained 12% in both saline and AP-18 injected groups 
over the course of the experiment, whereas those animals exposed to acrolein demonstrated a 
minor (4%) weight loss in both saline and AP-18 injected groups after the first exposure day.  
However, the rates of weight gain after the initial exposure were identical in all groups.   Laser 
Doppler flowmetry.  Laser Doppler flowmetry was performed as previously described (9).  
Male rats were anesthetized with ketamine/xylazine (80 and 10 mg/kg body weight, 
respectively), followed by additional doses of ketamine/xylazine (40 and 5 mg/kg body weight) 
as needed.  Body temperature was maintained at 37° C with a homeothermic blanket.  For the 
measurement of meningeal blood flow, the skull was fixed in a stereotaxic frame and a cranial 
window prepared (9) with the dura left intact.  Dural blood flow was measured with a laser 
Doppler flowmeter (TSI, MN).  A needle type probe was placed over a large branch of the 
middle meningeal artery (MMA), distant from visible cortical blood vessels and the cranial 
window kept moist with synthetic interstitial solution (SIF) consisting of: 135 mM NaCl, 5 mM 
KCl, 5 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 10 mM D-glucose (pH 7.3).  Blood flow was 
sampled at 1Hz with a Digidata 1320 interface using Axoscope software (Axon Instruments, 
CA).  
Blood flow drug administration.  To stimulate the nasal mucosa, 25 µl of test 
compound or vehicle solution was applied over a 30 sec period at a site 2 mm into the right 
nostril using a Pipetman pipette (9;28).  Solutions of mustard oil (Sigma) were prepared fresh 
daily by diluting in SIF to the desired concentrations.  Stock solutions of capsaicin (10 mM; 
Sigma) were dissolved in ethanol and stored at -20°C and then diluted to the desired 
concentration with SIF prior to use.  A thirty minute stabilization period preceded all test drug 
applications to ensure steady basal blood flow measurements.  Each animal in blood flow 
experiments (Figures 1, 4-6) was given nasal saline as a vehicle for mustard oil testing or saline 
containing  0.0001% ethanol as a vehicle for capsaicin testing 15 min before administering the 
TRP agonist.  Saline or vehicle controls produced  less than 2% change in blood flow on average 
consistent with our previous published results (9;21) (data not shown).  Thirty minutes after TRP 
agonist administration, 50 µl of 3 M KCl was administered to the dura to assess the integrity of 
meningeal blood vessel responses.  Some rats received a single injection of saline two hours 
before or AP-18 either two hours or 27 hours before blood flow drug administration.  Following 
completion of the blood flow experiments, each rat was decapitated and the brain removed.  The 
underlying left TG was rapidly removed, frozen on dry ice and stored at -80°C for later qPCR 
analysis.  The right TG was fixed in situ by placement of the skull into 4% paraformaldehyde in 
0.1 M PBS (pH 7.4). 
Immunocytochemistry.  To determine whether irritant exposure altered the number of 
TRPV1- or CGRP-positive TG neurons, immunocytochemistry was performed.  Following 
overnight fixation, the TG was removed from the skull and placed in PBS and then cryoprotected 
in 10% sucrose for 2 hrs followed by 20% sucrose in PBS overnight at 4°C.  Tissues were cut to 
35 µm in thickness and collected free-floating in PBS.  For immunofluorescent labeling, sections 
were rinsed in PBS and blocked in 4% normal goat serum and 0.025% Triton-X100 in PBS for 1 
hr.  The sections were then incubated with the primary antibody (rabbit anti-TRPV1 C-terminus 
(29); dilution 1:7500 or mouse anti-CGRP (Sigma) dilution 1:2000) diluted in blocking solution 
overnight at 4°C.  Subsequently, sections were rinsed in PBS and incubated with the secondary 
antibody (Dylight 549-conjugated to goat anti-rabbit IgG, dilution 7.5 µg/ml, Jackson 
ImmunoResearch or Alexa Fluor 488 goat anti-mouse, dilution 7.5 µg/ml, Jackson 
ImmunoResearch) for 1 hr at room temperature.  The sections were rinsed, mounted on slides, 
and treated with Prolong Gold antifade reagent (Life Technologies) before coverslips were 
affixed.  Fluorescent images were acquired with a 4x objective and cell counts conducted in 
Photoshop (Adobe).  TG sections containing all 3 subdivisions were used for cell counts.  No 
reactivity was observed in control sections in which primary antibody was omitted. 
RNA isolation and quantitative RT-PCR. RNA from homogenized TG tissue lysate 
(25 – 30 mg) was isolated and purified using the RNeasy Mini Kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions.  Genomic DNA was removed from isolated RNA 
with TURBO DNAse (Life Technologies, Foster City, CA) and yield and purity were determined 
on a Nanodrop ND-1000 Spectrophotometer (Thermoscientific, Franklin, MA).  A260/A280  ratios 
were between 2.0 and 2.2 for all samples.  Single-stranded cDNA was synthesized from 1 µg 
mRNA using reverse transcriptase (Superscript II reverse transcriptase, Life Technologies) and 
Oligo(dT)12-18 primers (Life Technologies). 
Quantitative PCR (qPCR) reactions were run in triplicate on an ABI PRISM 7900HT 
Sequence Detection System (Life Technologies).  The cDNA was amplified for quantitative RT-
PCR with SYBR Green PCR Master mix (Life Technologies) and gene specific primers (TRPV1 
– 800 nM, TRPA1 – 200 nM or β-actin – 400 nM).  The primers for amplification of rat TRPV1 
(Trpv1, Ref NM_031982.1) message were as follows: TRPV1 forward (5’-AGG ACC CAG 
GCA ACT GTG-3’, TM =58° C) and TRPV1 reverse (5’-ATC CCT CAG AAG GGG AAC C-3’, 
TM = 56° C).  These primers span exons 15 and 16, align with nucleotides 2456- 2474 and 2362 
– 2379 and produce a 113 bp product.  The primers for amplification of rat TRPA1 (Trpa1, Ref 
NM_207608.1) were as follows:  TRPA1 forward (5’-GCC CCT GTC TCT GTA AAT AAC C-
3’, TM = 55° C) and TRPA1 reverse (5’-CTT GTG TCG CTG ATG TCT TG-3’, TM = 54° C).  
These primers span exons 11and 12, align with nucleotides 1276-1297 and 1402-1421 and yield 
a 146 bp product.  The primers for β-actin (Actb, Ref NM_031144.2) were as follows:  β-Actin 
forward (5’-CAC TTT CTA CAA TGA GCT GCG-3’, TM = 54° C) and β-actin reverse (5’-CTG 
GAT GGC TAC GTA CAT GG-3’, TM = 55° C).  The primers span exons 4 and 5, align with 
nucleotides 345-365 and 473-492 and yield a 148 bp product.  A mixture of cDNA template, 
SYBR Green Master mix and forward and reverse primers was treated with uracil N-glycosylase 
(Life Technologies) before undergoing the following protocol:  50°C for 2 min, 95°C for 10 min, 
then 45 cycles of 95°C for 15 s, 60°C for 1 min, followed by 1 cycle of 95°C for 15 s, 60°C for 
15s, and 95°C for 15 s.  The PCR products were analyzed with ABI PRISM sequence detection 
software.  The specificity of these amplifications was verified by melt curve analysis with 
detection of only a single peak.  Reactions containing no reverse transcriptase (RT) or no 
template were also run as additional negative controls. 
Real-time quantitative PCR data was analyzed with the ΔΔCT method as described by 
Livak and Schmittgen (2001) (30).  TRPA1 or TRPV1 transcript levels were compared in 
trigeminal ganglia of room air (control) and acrolein exposed animals.  TRPV1 or TRPA1 values 
were normalized to β-actin and calibrated to control data using the ΔΔCT method.  β-actin was 
used as a reference gene and its level was not altered across these experimental conditions.  The 
quantification cycle (Cq) was defined as the number of cycles required to attain a fluorescence 
threshold of 0.2 units.   
Data collection and statistics.  For blood flow experiments, data was collected at 1 Hz 
and filtered at 0.1 Hz for graphical representation.  Basal blood flow was determined as the mean 
flow rate measured during a 4 minute period prior to drug application and the effects of test 
compounds were calculated by comparing the peak response after drug or saline administration 
to the basal blood flow.  Changes in blood flow were calculated relative to the basal blood flow 
for each animal, averaged within treatment groups and expressed as percent changes.  
Comparison of blood flow changes and immunoreactive cell counts in the control and acrolein 
exposed groups were performed using a two-tailed Student’s t-test or ANOVA, respectively.  
qPCR results were calculated with the ΔΔCT method as described (30).  qPCR data are presented 
as relative expression levels.  Graphical presentation and statistical analysis was performed using 
GraphPad Prism software (GraphPad, CA).  Data values are presented as means ± SEM.  The 
significance level for all tests was set at p < 0.05.  
Results 
Acrolein exposure potentiates meningeal blood flow in response to TRPA1 and TRPV1 
agonists.   
Airborne chemical exposure is cited as a common trigger for migraine headache and has 
been linked to MCS an acquired disorder whose symptoms include headache.  Therefore we 
examined the effect of 4 days of periodic inhalation exposure (see Methods) to acrolein, a 
TRPA1 agonist and irritant common in indoor and outdoor pollution, on subsequent 
trigeminovascular responsiveness.  As shown in Figure 1A and C, daily repeated acrolein 
exposure significantly potentiated meningeal blood flow responses to acute nasal administration 
of a sub-maximal concentration of mustard oil (10 µM).  Representative traces of meningeal 
blood flow changes in response to nasal administration of mustard oil following room air or 
acrolein conditioning are shown in Figure 1A.  The blood flow changes are rapid and brief, 
peaking within the first 1-2 min before returning toward basal values within 10-15 minutes.  The 
data comparing peak blood flow in response to mustard oil in all animals conditioned to either 
acrolein or room air is summarized in Figure 1C.  Acrolein exposure significantly increased 
blood flow responses to mustard oil compared to room air controls (75 ± 24% (n = 9) vs 11 ± 3% 
(n = 7), p = 0.037).   
Because TRPA1 and TRPV1 receptors interact functionally (20) and TRPV1 expressing 
neurons are important for TRPA1 responses in the nasal-meningeal pathway (21), we also 
examined the effect of acrolein conditioning on blood flow responses to capsaicin, a TRPV1 
agonist.  As shown in Figure 1B and D, acrolein exposure significantly potentiated meningeal 
blood flow responses to acute nasal administration of a sub-maximal concentration of capsaicin 
(10 nM).  Representative traces of meningeal blood flow changes in response to nasal 
administration of capsaicin in animals periodically conditioned to room air or acrolein are shown 
in Figure 1B.  The summarized data (Figure 1D) demonstrate that acrolein exposure significantly 
increased blood flow responses to capsaicin compared to room air controls (71 ± 15% (n = 8) vs 
24 ± 10% (n = 6), p = 0.036).   
Acrolein exposure does not change the number of TRPV1 or CGRP immunoreactive 
neurons or TRPV1 or TRPA1 message levels in the trigeminal ganglion. 
 Sensitization of pain pathways has been linked to increased protein or message levels of 
important pain signaling molecules such as TRPV1 (31) or CGRP (32).  To determine whether 
altered TRPV1 or CGRP expression in the TG underlies the enhanced blood flow response, we 
compared TRPV1 and CGRP immunoreactive cell numbers between acrolein- and room air-
exposed animals (Figure 2).  Neither TRPV1 (Figure 2A) or CGRP (Figure 2B) immunoreactive 
cell counts were altered by the acrolein exposure paradigm.  Immunoreactive TRPV1 cell counts 
in acrolein exposed TG’s were similar to those of controls (350 ± 20.16 (n =13) vs 336.29 ± 
20.41 (n= 7), p = 0.53) as were CGRP expressing cells (255.3 ± 9.90 (n=13) vs 291.30 ± 18.99 
(n=7), p = 0.078).  Messenger RNA levels for TRPA1 or TRPV1 in trigeminal ganglia from 
animals exposed to room air or acrolein were also determined by qPCR (Fig. 3).  TRPV1 mRNA 
levels were not changed in acrolein exposed animals relative to room air exposed animals (0.90 ± 
0.09 (n=20) vs 1.0 ± 0.18 (n=10), p = 0.58).  Likewise, TRPA1 mRNA levels were not changed 
upon acrolein exposure (0.97 ± 0.12 (n=20) vs 1.0 ± 0.21 (n=10), p = 0.89).  As no changes in 
TRPV1 or CGRP immunoreactive cells or in TRPA1 or TRPV1 mRNA levels were detected we 
conclude that expression changes of these molecules are not critical  in the functional 
sensitization at the whole ganglion level.   
AP-18, a short acting TRPA1 antagonist blocks meningeal blood flow changes when 
administered 2 hours but not 27 hours before nasal administration of mustard oil 
We hypothesize that TRPA1 receptor activation mediates the sensitization of blood flow 
responses after acrolein.  To test this, we administered TRPA1 receptor antagonists or vehicle 
controls systemically during each acrolein inhalation exposure.  To demonstrate the efficacy of 
antagonists to interfere with TRPA1-dependent blood flow we first examined the ability of 
systemic AP-18, a potent but short acting TRPA1 antagonist to acutely block blood flow 
stimulated by nasal administration of 30 µM mustard oil.  AP-18 has been shown to acutely blunt 
responses in complete Freund’s adjuvant or formalin pain tests (33;34).  AP-18 (0.2 mg/kg, i.p.) 
administered two hours before blood flow measurement in response to nasal mustard oil nearly 
abolished blood flow compared to saline (Figure 4, 7 ±  4 (n = 5) vs. 66 ± 18 ( n = 12), p = 
0.007).  In contrast, when given 27 hours before blood flow measurements, AP-18 had no effect 
on mustard oil stimulated blood flow (60 ± 14 (n = 6) vs. 66 ± 18 ( n = 12), p = 0.80) compared 
to saline injected animals. This suggests that AP-18 while effective acutely (when given 
immediately before the inhalation periods) is no longer effective when blood flow is measured 
the day after inhalation exposures.    
Pretreatment with TRPA1 antagonist blocks acrolein-induced sensitization to TRPA1 and 
TRPV1 agonists 
To assess the involvement of TRPA1 in the sensitization phenomenon, we examined 
whether pretreatment with a TRPA1 antagonist during acrolein conditioning inhalations would 
block the subsequent potentiation.  AP-18,  was injected daily 30 min before placing an animal in 
the inhalation chamber.  Control animals received an injection of vehicle only.  Blood flow 
experiments were conducted approximately 22 hours after the last inhalation period and in the 
absence of vehicle or AP-18 injections.  Similar to the data in Figure 1, in vehicle injected 
animals, conditioning acrolein exposure potentiates the blood flow responses to 10 µM MO 
relative to room air exposure (Figure 5, 116 ± 32% (n=11) vs 37 ± 9% (n=13), p = 0.020).  AP-
18 pre-treatment significantly inhibited responses to 10 µM MO in both room air exposed and 
acrolein exposed animals (Figure 5) compared to vehicle injected animals (room air exposed, 5 ± 
1% (n=8) vs 37 ± 9% (n=13), p = 0.015; acrolein exposed, 6 ± 2% (n=8) vs 116 ± 32% (n=11), p 
= 0.011).   Interestingly, AP-18 also reduced MO responses in animals exposed to room air.  
While the mechanism is unclear, it is unlikely to involve a change in receptor gene expression as 
AP-18 did not alter message levels of TRPA1 or TRPV1 in room air or acrolein exposed animals 
in the trigeminal ganglion (data not shown).   
We also tested whether pre-treatment with AP-18 attenuated the acrolein-induced 
potentiation of blood flow in response to capsaicin.  A separate group of animals received AP-18 
or vehicle injections prior to exposure to acrolein or room air and their subsequent blood flow 
response to nasally administered capsaicin recorded.  Similar to the results in Figure 1, vehicle-
injected animals displayed a sensitized response to capsaicin (10 nM) following acrolein 
chamber exposure (Figure 6).  This increase was significant when comparing acrolein-exposed 
animals to those receiving room air (141 ± 27% (n=9) vs 14 ± 2% (n=12), p < 0.0001).  Blood 
flow responses to 10 nM capsaicin were not reduced in animals injected with AP-18 and exposed 
to room air  when  compared to the vehicle injected animals (9 ± 3% (n=6) vs 14 ± 2% (n=12),  p 
= 0.191).  However, blood flow responses to 10 nM capsaicin were attenuated in animals 
injected with AP-18 and exposed to acrolein  compared to the vehicle injected animals exposed 
to acrolein (26 ± 12% (n=6) vs 141 ± 27% (n=9),  p = 0.006).  
Discussion  
Headache is the most common symptom of air pollution and studies have demonstrated 
that poor air quality is correlated with increases in ER visits due to headache (2-4;35), but few 
clinical studies have addressed the mostly anecdotal observations.  In our previous studies (9;21) 
we suggested that inhalation of environmental irritants may excite trigeminal neurons supplying 
the nose and airways through TRPA1 receptors and subsequently cause trigeminovascular 
activation leading to headache.  Intranasal administration of the irritants mustard oil or capsaicin 
induced dilatation of meningeal blood vessels via a CGRP-dependent mechanism (9).  Ablation 
of TRPV1 expressing neurons in the trigeminal ganglia significantly decreased irritant induced 
meningeal vasodilatation and TRPA1 and CGRP expression in the trigeminal ganglia (21), 
consistent with the notion that TRP receptor activation and CGRP release from the 
trigeminovascular network of neurons are contributing mechanisms of headache.  
Headache, as well as other symptoms, is associated in Multiple Chemical Sensitivity and 
Sick Building Syndrome, acquired disorders strongly linked to chemical exposure (5).  Usually 
such chemical exposures are via inhalation and lead to hypersensitivity to environmental irritants 
following either acute or chronic exposures.  Like air pollution exposure, the pathophysiological 
mechanisms that induce headache in these syndromes are unknown, but may involve 
sensitization of peripheral neural elements.  We examined whether chronic exposure to 
environmental irritants would induce sensitization, by exposing rats to the environmental irritant 
acrolein, a TRPA1 receptor agonist, through inhalation.  Consistent with this hypothesis, daily 
acrolein exposure sensitized the trigeminovascular response to intranasal TRP agonist 
administered 24 hours later.  Interestingly, trigeminovascular responses to both the TRPA1 
agonist mustard oil and the TRPV1 receptor agonist capsaicin were enhanced by acrolein 
exposure.  No changes in tissue expression levels of either TRPA1 or TRPV1 or of CGRP-
positive cell counts in the whole ganglion were observed following acrolein exposure.  These 
data suggest that if the molecular locus of sensitization to activation of either TRP receptor 
subtype is in the sensory neuron that the convergence may occur in signaling events downstream 
of and critical to both receptors.  As we could not quantitatively assess expression in 
subpopulations, we cannot rule out changes in message or protein levels specific to only the 
nasal-meningeal pathway.  An alternate explanation for the observed sensitization may be 
agonist-induced membrane trafficking of TRPA1 receptors as has been previously described 
(36).  While a complete understanding of the mechanism of sensitization will require further 
studies, the fact that daily administration of the TRPA1 receptor antagonist, AP-18, prior to 
acrolein exposure eliminated agonist sensitization strongly implicates TRPA1 activation in the 
sensitization phenomenon itself, regardless of the molecular element manifesting the 
sensitization.   
One potential confound relates to whether chronic exposure to TRPA1 agonists may 
induce general tissue damage, yet few studies have investigated this question.  Hazari and 
colleagues observed acute cardiac pathophysiology following short term exposure of rats to 
acrolein (37;38).  They reported that a single diesel exhaust or acrolein exposure increased the 
sensitivity and incidence of arrhythmia, both immediately and 24 hrs post exposure.  Although 
we did not monitor heart function in our study, the concentration of acrolein we employed was 
10-fold less than in their studies.  Olfactory mucosal damage and respiratory epithelial 
metaplasia has been reported after sub-chronic exposure to acrolein levels over 0.67 ppm, while 
lower levels resulted in only minor epithelial changes (26;27).  Together these studies suggest 
that while exposure to high levels of acrolein, either acute or chronic, may induce tissue injury 
and inflammatory responses, exposure to lower concentrations such as employed here induces 
minimal damage.   
To our knowledge this is the first demonstration of sensitization of trigeminovascular 
responses after environmental irritant exposure.    As we observed no changes in TRPA1 or 
TRPV1 mRNA expression levels or numbers of TRPV1 and CGRP expressing cells in the TG it 
seems more likely that posttranslational or other downstream events may be important.  For 
example, PKA/PLC signaling and membrane trafficking of the TRPA1 receptor were implicated 
in the reduced pain thresholds observed after repeated injections of mustard oil in mice (36).  
Likewise, repeated application of mustard oil to the nasal cavity in humans produced 
sensitization when a second stimulus was delivered shortly after the first stimulus, however the 
mechanism was not explored (39).  Our observation that acrolein exposure potentiates capsaicin 
as well as mustard oil responses highlights the complexity of TRPA1-TRPV1 interactions in 
sensory neurons (reviewed by Akopian, 2011(20)).  TRPA1 and TRPV1 can form 
heteromultimers which exhibit unique desensitization properties such that TRPV1 controls the 
density of TRPA1 on the cell surface (20).  In addition, both receptors are modulated by 
inflammatory mediators, such as bradykinin. It is possible that the acrolein exposure paradigm 
used here could result in release of such inflammatory mediators which wouldsubsequently 
activate and sensitize trigeminal neurons.   
The irritant exposure paradigm used here produces long-lasting excitation of the 
trigeminovascular response and bears some similarities to previously described chronic migraine 
models where repeated activation of peripheral trigeminal nerve terminals produces long-lasting 
hyperexcitabilty (40;41).  In these models, other attributes of chronic migraine which reflect 
central sensitization were observed including changes in behavior (periorbital allodynia) and in 
signaling molecules such as c-FOS or neurotransmitters in the trigeminal nucleus caudalis.  It is 
not clear whether the sensitization observed after irritant exposure reflects both central and 
peripheral sensitization or just peripheral because the nasal-meningeal pathway underlying the 
phenomenon is not yet well-defined.  In this regard utilizing double retrograde labeling from the 
nose and meninges we observed that single trigeminal neurons do not project axons to both nasal 
epithelium and meninges (21).  Instead separate populations of cell bodies innervating the nose 
or meninges reside next to each other in the trigeminal ganglion,  thus we hypothesize that the 
nasal-meningeal pathway for trigeminovascular activation is through intraganglionic 
transmission.  Alternatively, a central relay cannot be definitively ruled out at this time.  Future 
studies will determine the duration and mechanism of the sensitization as well as whether irritant 
exposure produces characteristics of central sensitization.   
Taken together our results suggest a mechanism for the enhanced headache susceptibility 
after airborne chemical exposure.  This novel model may allow us to gain a better understanding 
of migraine triggers and perhaps the progression to chronic migraine. 
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Clinical and public health implications: 
• Air pollution and chemical odors are widely cited headache triggers 
• Inhalation exposure to environmental irritants sensitizes trigeminovascular responses to 
painful stimuli 
• TRPA1 antagonists attenuate trigeminovascular sensitization induced by environmental 
irritants  
Figure Legends 
Figure 1.  Blood flow changes in the middle meningeal artery after nasal administration of 
mustard oil (A, C) or capsaicin (B, D) after exposure to acrolein vapor or room air. (A, B) 
Representative traces of middle meningeal blood flow in response to nasally administered 
mustard oil (A) or capsaicin (B) after acrolein vapor or room air.  Laser Doppler flowmetry 
measurements were collected at 1 Hz and filtered at 0.1 Hz for graphical representation.  Arrows 
indicate nasal administration of agonist.  (B, D) Compared to room air-exposed animals, blood 
flow response to nasal mustard oil or capsaicin was significantly increased in acrolein-exposed 
animals.  Values are means ± S.E.M.  Number of animals per group is indicated.  P < 0.05 
compared to blood flow changes in room air-exposed animals.   
Figure 2.  TRPV1 receptor and CGRP immunoreactivity in trigeminal ganglia of rats exposed to 
acrolein or room air.  (A) TRPV1 receptor immunoreactive cell counts do not differ in V1, V2 or 
V3 divisions or total trigeminal ganglion in rats exposed to acrolein compared to room air.  (B) 
CGRP immunoreactive cell counts do not differ in V1, V2 or V3 divisions or total trigeminal 
ganglion in rats exposed to acrolein compared to room air.  Cell counts per section are 
represented as mean ± S.E.M.  Number of animals per group is indicated. 
Figure 3.  Relative expression levels of TRPV1 and TRPA1 mRNA do not change in trigeminal 
ganglia of rats exposed to acrolein vs room air.  Each samples values are normalized to β-actin 
values using the ΔΔCT method and averaged across groups.  Values are represented as mean ± 
S.E.M.  N = 10-20 animals per group.    
Figure 4.  Effects of systemic AP-18 on nasal administration of 30 µM mustard oil.  AP-18 
administered two hours before nasal mustard oil, significantly attenuated peak blood flow 
responses compared to saline administration 2 hours before nasal mustard oil (*, p <  0.05).  In 
contrast, AP-18 administered 27 hours before nasal mustard oil had no effect on blood flow 
responses.  Values are means ± S.E.M.  Number of animals per group is indicated.  Note that 30 
µM mustard oil is used in this experiment because the animals have not been exposed to 
acrolein.   
Figure 5.  Effects of daily administration of TRPA1 antagonist (AP-18) prior to each inhalation 
exposure on blood flow changes in response to 10 µM mustard oil.  In vehicle-injected animals 
the blood flow response to nasal mustard oil was significantly increased in acrolein-exposed 
animals compared to room-air exposed (#, p < 0.05).  Compared to vehicle treated controls, 
blood flow response to nasal mustard oil was decreased in AP-18 injected animals in room air (*, 
p < 0.05) and acrolein exposed animals (**, p < 0.05).  Values are means ± S.E.M.  Number of 
animals per group is indicated.   
Figure 6.  Effects of daily administration of the TRPA1 antagonist AP-18 prior to each inhalation 
exposure on blood flow changes in response to nasal administration of 10 nM capsaicin.  
Compared to vehicle treated controls, blood flow response to nasal mustard oil was decreased in 
AP-18 injected animals in acrolein exposed animals (**, p < 0.05) but not in room air exposed 
animals.  Values are means ± S.E.M.  Number of animals per group is indicated.   
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